Future Science Group期刊
期刊
会议
图书
作者:Tarek Assi , Alina Danu , Christine Mateus ...
来源:[J].Immunotherapy(IF 2.393), 2019, Vol.11 (7), pp.591-598Future Science Group
摘要:The most recent progress in the oncology field has led to a paradigm shift in the management of cancer with the tsunami of immune checkpoint inhibitors that are associated with a particular pattern of immunological adverse events. This is a case of a 54-year-old woman that d...
作者:Yanyan Lou , Julian A Marin-Acevedo , Prakash Vishnu ...
来源:[J].Immunotherapy(IF 2.393), 2019, Vol.11 (7), pp.577-584Future Science Group
摘要:Immune checkpoint inhibitors have changed the treatment paradigm for patients with cancer. Though a majority of patients tolerate treatment, some develop hematologic toxicities, including eosinophilia. Eosinophilia has been associated with better responses in some patients with m...
作者:James RM Black , Robert D Goldin , Matthew Foxton ...
来源:[J].Immunotherapy(IF 2.393), 2019, Vol.11 (7), pp.585-590Future Science Group
摘要:Immune-related hepatitis is an important toxicity from immune-checkpoint inhibitor therapy, affecting up to 20% of patients on dual cytotoxic T-lymphocyte antigen 4/programmed cell death 1 (CTLA-4/PD-1) inhibitors. The mechanisms underlying this type of drug-induced liver ...
作者:Vincenzo Di Nunno , Veronica Mollica , Lidia Gatto ...
来源:[J].Immunotherapy(IF 2.393), 2019, Vol.11 (7), pp.631-643Future Science Group
摘要:Aim: Estimate prognosis and clinical outcome of patients with localized or metastatic renal cell carcinoma (RCC) is an important issue which drive our medical decisions. Methods: We carried out a meta-analysis of available clinical studies exploring neutrophil-to-lymphocyte ...
作者:Daniel Wendling
来源:[J].Immunotherapy(IF 2.393), 2019, Vol.11 (7), pp.557-560Future Science Group
作者:Gang Liu , Xiaoyan Fan , Ying Cai ...
来源:[J].Immunotherapy(IF 2.393), 2019, Vol.11 (7), pp.599-616Future Science Group
摘要:Aim: To produce dendritic cells (DCs) from CD34+ stem cells from cord blood and explore their prophylactic and curative effect against tumors by vaccinating humanized NSG mice. Materials & methods: Separated CD34+ stem cells from cord blood were cultured for...
来源:[J].Immunotherapy(IF 2.393), 2019, Vol.11 (7), pp.645-645Future Science Group
作者:Dusko Ilic
来源:[J].Regen. Med.(IF 3.873), 2019, pp.-Future Science Group
摘要:Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions in February 2019.
作者:Fernando Franco , Miriam Méndez , Lourdes Gutierrez ...
来源:[J].Immunotherapy(IF 2.393), 2019, Vol.11 (5), pp.379-384Future Science Group
摘要:The immunotherapy (IO) agents in the renal cell carcinoma represent the best option in the second line of treatment. However, these drugs can be associated with different types of toxicities. The vascular toxicity related with IO is very uncommon. We report a case of a 46-year-ol...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×